1. Home
  2. GOSS vs VBNK Comparison

GOSS vs VBNK Comparison

Compare GOSS & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • VBNK
  • Stock Information
  • Founded
  • GOSS 2015
  • VBNK 1980
  • Country
  • GOSS United States
  • VBNK Canada
  • Employees
  • GOSS N/A
  • VBNK N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • VBNK Commercial Banks
  • Sector
  • GOSS Health Care
  • VBNK Finance
  • Exchange
  • GOSS Nasdaq
  • VBNK Nasdaq
  • Market Cap
  • GOSS 347.8M
  • VBNK 370.1M
  • IPO Year
  • GOSS 2019
  • VBNK 2021
  • Fundamental
  • Price
  • GOSS $1.96
  • VBNK $10.78
  • Analyst Decision
  • GOSS Strong Buy
  • VBNK Strong Buy
  • Analyst Count
  • GOSS 4
  • VBNK 4
  • Target Price
  • GOSS $8.50
  • VBNK $17.50
  • AVG Volume (30 Days)
  • GOSS 3.2M
  • VBNK 73.2K
  • Earning Date
  • GOSS 08-05-2025
  • VBNK 09-04-2025
  • Dividend Yield
  • GOSS N/A
  • VBNK 0.66%
  • EPS Growth
  • GOSS N/A
  • VBNK N/A
  • EPS
  • GOSS N/A
  • VBNK 0.79
  • Revenue
  • GOSS $40,237,000.00
  • VBNK $79,960,487.00
  • Revenue This Year
  • GOSS N/A
  • VBNK $9.02
  • Revenue Next Year
  • GOSS $63.97
  • VBNK $42.18
  • P/E Ratio
  • GOSS N/A
  • VBNK $15.36
  • Revenue Growth
  • GOSS N/A
  • VBNK N/A
  • 52 Week Low
  • GOSS $0.66
  • VBNK $8.51
  • 52 Week High
  • GOSS $2.23
  • VBNK $18.38
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 58.35
  • VBNK 43.90
  • Support Level
  • GOSS $1.67
  • VBNK $11.00
  • Resistance Level
  • GOSS $2.00
  • VBNK $11.16
  • Average True Range (ATR)
  • GOSS 0.17
  • VBNK 0.34
  • MACD
  • GOSS -0.02
  • VBNK -0.07
  • Stochastic Oscillator
  • GOSS 52.21
  • VBNK 36.96

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

Share on Social Networks: